ESR-REIT Valuation

Q: What is the Fair Price of UZ0 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

UZ0 (€0.16) is trading below our estimate of [[fair value]] (€0.24)

Is UZ0 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

6/6

Valuation Score 6/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of UZ0 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: UZ0 (€0.16) is trading below our estimate of fair value (€0.24)

Significantly Below Fair Value: UZ0 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for UZ0?

Key metric: As UZ0 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for UZ0. This is calculated by dividing UZ0's market cap by their current revenue.
What is UZ0's PS Ratio?
PS Ratio	5.5x
Sales	S$374.31m
Market Cap	S$2.05b

UZ0 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	11.1x
Enterprise Value/EBITDA	n/a
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does UZ0's PS Ratio compare to its peers?

The above table shows the PS ratio for UZ0 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	7.9x
AOX alstria office REIT-AG	5.4x	-1.5%	€1.3b
HABA Hamborner REIT	4.9x	-1.2%	€518.2m
MONT Montea Comm. VA	11x	9.8%	€1.5b
FMTY 14 Fibra MtyP.I. de	10.4x	12.5%	Mex$26.8b
UZ0 ESR-REIT	5.5x	3.9%	€2.0b

Price-To-Sales vs Peers: UZ0 is good value based on its Price-To-Sales Ratio (5.5x) compared to the peer average (7.9x).

Price to Sales Ratio vs Industry

How does UZ0's PS Ratio compare vs other companies in the Global Industrial REITs Industry?

1 Company	Price / Sales	Estimated Growth	Market Cap

1 Company		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: UZ0 is good value based on its Price-To-Sales Ratio (5.5x) compared to the Global Industrial REITs industry average (8.6x).

Price to Sales Ratio vs Fair Ratio

What is UZ0's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

UZ0 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	5.5x
Fair PS Ratio	7.3x

Price-To-Sales vs Fair Ratio: UZ0 is good value based on its Price-To-Sales Ratio (5.5x) compared to the estimated Fair Price-To-Sales Ratio (7.3x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst UZ0 forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	€0.16	€0.24 +49.2%	4.5%	€0.25	€0.23	n/a	5
Dec ’25	€0.16	€0.24 +45.5%	4.5%	€0.25	€0.23	n/a	5
Nov ’25	€0.18	€0.23 +32.2%	4.5%	€0.25	€0.22	n/a	5
Oct ’25	€0.18	€0.23 +25.9%	4.5%	€0.25	€0.22	n/a	5
Sep ’25	€0.17	€0.23 +40.3%	4.5%	€0.25	€0.22	n/a	5
Aug ’25	€0.17	€0.23 +37.8%	4.5%	€0.25	€0.22	n/a	5
Jul ’25	€0.17	€0.24 +42.8%	7.5%	€0.27	€0.22	n/a	5
Jun ’25	€0.18	€0.24 +35.3%	8.5%	€0.27	€0.22	n/a	5
May ’25	€0.18	€0.24 +36.2%	8.0%	€0.27	€0.22	n/a	6
Apr ’25	€0.18	€0.24 +33.7%	7.4%	€0.27	€0.22	n/a	6
Mar ’25	€0.19	€0.24 +30.0%	6.9%	€0.27	€0.22	n/a	7
Feb ’25	€0.19	€0.24 +25.6%	9.2%	€0.28	€0.21	n/a	9
Jan ’25	€0.20	€0.24 +22.1%	10.1%	€0.28	€0.21	n/a	9
Dec ’24	€0.19	€0.24 +29.9%	10.1%	€0.28	€0.21	€0.16	9
Nov ’24	€0.17	€0.24 +43.0%	10.1%	€0.28	€0.21	€0.18	9
Oct ’24	€0.17	€0.25 +46.7%	6.9%	€0.27	€0.21	€0.18	9
Sep ’24	€0.19	€0.25 +32.9%	6.9%	€0.27	€0.21	€0.17	9
Aug ’24	€0.21	€0.26 +21.6%	9.1%	€0.31	€0.21	€0.17	9
Jul ’24	€0.21	€0.26 +25.0%	9.9%	€0.30	€0.20	€0.17	9
Jun ’24	€0.20	€0.27 +35.1%	9.7%	€0.31	€0.22	€0.18	9
May ’24	€0.20	€0.27 +34.4%	9.3%	€0.31	€0.22	€0.18	9
Apr ’24	€0.20	€0.28 +38.4%	10.4%	€0.31	€0.22	€0.18	9
Mar ’24	€0.21	€0.28 +36.5%	10.4%	€0.32	€0.22	€0.19	8
Feb ’24	€0.24	€0.30 +22.8%	11.7%	€0.38	€0.26	€0.19	8
Jan ’24	€0.21	€0.31 +45.4%	13.4%	€0.38	€0.24	€0.20	8
Dec ’23	€0.22	€0.31 +39.5%	13.4%	€0.38	€0.24	€0.19	8

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.